MedTrace Logo

A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers

NCT06231953 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2024-01-30

No results posted yet for this study

Summary

This is a prospective, multi-center clinical study of Multi-Cancer Early Detection (MCED) testing in cancer patients and healthy volunteers. The purpose of this study is to establish MCED platform through the analysis of whole genome sequencing of circulating DNA.

The study will enroll 4,000 subjects as defined by eligibility criteria at up to 10 clinical institutions in South Korea.

Conditions

  • Invasive Cancer
  • Healthy Volunteer

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Joohyuk Sohn · Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-13
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06231953 on ClinicalTrials.gov